Results 251 to 260 of about 188,535 (344)

Development and validation of a high-performance clinical predictive model for early identification of non-alcoholic fatty liver disease. [PDF]

Front Physiol
Liang T, Ren J.
europepmc   +1 more source

The ontogeny of hepatic detoxification in children : implications for pediatric non-alcoholic fatty liver disease

, 2011
Shogo John Miyagi
openalex   +1 more source

High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths [PDF]

, 2019
Francesco De Chiara, Cynthia Ureta Checcllo, Javier Ramón‐Azcón   +2 more
openalex   +1 more source

Anti‐Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea

Chronic Diseases and Translational Medicine, EarlyView.
Cellular and molecular mechanisms of obesity‐related obstructive sleep apnea (OSA). ADMA: asymmetric dimethyrarginine, NLRP3: nucleotide‐binding domain, leucine‐rich repeat family, Pyrin domain containing 3, TLR: toll‐like receptors, IL‐1β: interleukin‐1β, IL‐6: interleukin‐6; LPS: lipopolysacharide, ROS: reactive oxygen species, TNF‐α.
Anish Preshy, Cornelius J. Fernandez, Mohammad Hamid Nedai, Joseph M. Pappachan   +3 more
wiley   +1 more source

Evaluation of Liver Fibrosis and Metabolic Risk in Non-Alcoholic Fatty Liver Disease.

J Pharm Bioallied Sci
Bansal G, Jedhe VM, Akram M.
europepmc   +1 more source

Tea Polysaccharides Ameliorates Non-Alcoholic Fatty Liver Disease in Mice via Regulating Macrophages Polarization by Gut Microbial Metabolites. [PDF]

Curr Issues Mol Biol
Liu D, Li A, Li P.
europepmc   +1 more source

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions [PDF]

, 2012
Pietro Vajro, S. Lenta, Claudio Pignata, Mariacarolina Salerno, Roberta D’Aniello, I. De Micco, Giulia Paolella, Giancarlo Parenti   +7 more
openalex   +1 more source

Frailty and Cardiovascular Events as Determined by Body Composition: A Systematic Review

Chronic Diseases and Translational Medicine, EarlyView.
Frailty phenotypes and risk of cardiovascular disease. Sarcopenic obese phenotype is associated with increased prevalence of cardiovascular risk factors and progression of metabolic syndrome, leading to cardiovascular events and cardiovascular mortality, while the Anorexic malnourished phenotype is associated with reduced prevalence of cardiovascular ...
Ishleen Oberoi, Shabnam Tariq, Kristian Arak, Mhd Alaa Aldin Al‐Haffar, Kyaw Thet, Ahmed H. Abdelhafiz   +5 more
wiley   +1 more source

The evolution of artificial intelligence technology in non-alcoholic fatty liver disease. [PDF]

Front Radiol
He J, Wu Y, Lin Z, He R, Zhuo L, Li Y.
europepmc   +1 more source

GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes

Chronic Diseases and Translational Medicine, EarlyView.
Endogenous GLP‐1 and exogenous GLP‐1 RAs activate GLP‐1R‐expressing vagal afferents in the portal vein, projecting to the nucleus tractus solitarius (NTS). This input engages brainstem–hypothalamic circuits that regulate metabolic homeostasis. Hypothalamic efferent vagal output to the liver suppresses lipogenesis, enhances triglyceride export, and ...
Gabriel Amorim Moreira Alves, Masatoki Teranishi, Rajendranandini Majumdar, Fazal Khan, Mohan Dodeja, Ana Claudia Teixeira de Castro Gonçalves Ortega, Marco Acerboni, Arosh S. Perera Molligoda Arachchige, Frank James   +8 more
wiley   +1 more source